💰NIH Closed Meetings for Grant Applications and Review
The Department of Health and Human Services announces closed meetings of the Center for Scientific Review for evaluating grant applications. The meetings, which will be conducted virtually, focus on various health-related topics and include discussion of confidential materials. The sessions are crucial for stakeholders seeking NIH funding opportunities.
Learn More🚬FDA Correction Notice on Tobacco Research Development Meetings
The document is a correction to a previous notice by the Department of Health and Human Services concerning meetings with industry and investigators related to the research and development of tobacco products. This correction clarifies the subject line for improved accuracy in communication.
Learn More🩺CMS Notice for Proposed Information Collection on CLIA Applications
The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information (including each proposed extension or reinstatement of an existing collection of information) and to allow 60 days for public comment on the proposed action. Interested persons are invited to send comments regarding our burden estimates or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency's functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden.
Learn More📄FDA Information Collection Activities and Approvals Summary
The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
Learn More🧪FDA Notice
The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on information collection associated with implementation of the Clinical Laboratory Improvement Amendments of 1988 (CLIA).
Learn More🏥FDA Information Collection Activities Announcement - Business Overview
The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
Learn More🧬Government-Owned Inventions Available for Licensing
The invention listed below is owned by an agency of the U.S. Government and is available for licensing to achieve expeditious commercialization of results of federally funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing.
Learn More🧪Notice of Public Meeting on Alternative Toxicological Methods
The National Institute of Environmental Health Sciences announces a virtual meeting for the Scientific Advisory Committee on Alternative Toxicological Methods (SACATM). The committee advises on alternative methods for toxicological assessments and invites public comments and participation, emphasizing its importance in shaping industry regulations and practices.
Learn More🏥NIH Announces Closed Meetings for Grant Review Applications
The National Institutes of Health has issued a notice regarding upcoming closed meetings held by the Center for Scientific Review to evaluate grant applications. These meetings, scheduled virtually from August 5 to 12, 2025, will focus on diverse topics related to health and research, including immunology, neurodevelopment, and substance use disorders.
Learn More🦠Exclusive License Opportunity for Engineered Commensal Bacteria Technology
The National Institute of Allergy and Infectious Diseases, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive, Inter- Institutional Agreement-Institution Lead to CZ Biohub SF, LLC ("CZB"), located in San Francisco, California, in its rights to the technologies and patent applications listed in the Supplementary Information section of this notice.
Learn More